Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2989495 | 0.76 | ALDH1A1 (0.36) | — | |
| SCHEMBL4411047 | 0.69 | RET (0.46) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL2990859 | 0.69 | RET (0.41) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL14393350 | 0.67 | MAPK14 (0.49) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL14325015 | 0.67 | MAPK14 (0.49) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL3702183 | 0.67 | RET (0.45) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL8316378 | 0.67 | RET (0.45) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL596246 | 0.67 | RET (0.53) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL177080 | 0.67 | MAPK14 (0.49) | RETMAPK14CAMK1DTBXA2RHDAC6 | |
| SCHEMBL9426196 | 0.67 | RET (0.49) | RETMAPK14CAMK1DTBXA2RHDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6828283-B2 | Traction fluids in toroidal continuously variable transmission (T-CVT) systems | GENBERAL MOTORS CORPORATION | 2004-12-07 | — | — | US | claimed |
| US-20040152931-A1 | Traction fluid with alkane bridged dimer | GM Global Technology Operations LLC | 2004-08-05 | — | — | US | claimed |
| EP-2009304-B1 | TORQUE LIMITER | JTEKT CORP (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2003353-B1 | TORQUE LIMITER | JTEKT CORP (JP) | 2014-06-04 | — | — | EP | disclosed |
| US-8230986-B2 | Torque limiter | JTEKT CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8220609-B2 | Torque limiter | JTEKT CORPORATION (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20100184519-A1 | TORQUE LIMITER | JTEKT CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20090173591-A1 | TORQUE LIMITER | JTEKT CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-2009304-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-31 | — | — | EP | disclosed |
| EP-2003353-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-6828283-B2 | Traction fluids in toroidal continuously variable transmission (T-CVT) systems | GENBERAL MOTORS CORPORATION | 2004-12-07 | — | — | US | disclosed |
| US-20040152931-A1 | Traction fluid with alkane bridged dimer | GM Global Technology Operations LLC | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152931-A1 | Traction fluid with alkane bridged dimer | CCL11, CCL2, TLN1 | RET 2395/4885MAPK14 1616/4885CAMK1D 1540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.